Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: August 10, 2001
Last updated: June 20, 2013
Last verified: October 2004
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2006
  Estimated Primary Completion Date: No date given